Nasdaq grants Iveda 180-day extension to regain $1 minimum bid price compliance - IVDA News | RalliesNasdaq grants Iveda 180-day extension to regain $1 minimum bid price compliance
I
IVDA• Nasdaq grants extension for bid-price compliance
- Nasdaq granted Iveda Solutions an extra 180 days, through March 1, 2027, to regain compliance with the $1 minimum bid rule.
- The stock must close at or above $1 for at least 10 consecutive business days during the extension to cure the deficiency.
- Nasdaq said the company met other continued-listing standards, including market value of publicly held shares.
- Management may consider a reverse stock split as a potential remedy, with no decision announced.
- The notice has no immediate impact on trading, with shares remaining listed on the Nasdaq Capital Market.
RXO
•
